JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
PUT
Chubb
CB
$128B
| $3.01M | ﹤0.01% |
10,900
| – | – |
2020 Q4
16 quarters
|
|
|
DX
3702
Dynex Capital
DX
$2.73B
| $3M | ﹤0.01% |
237,316
-152,784
| -39% | -$1.9M |
2016 Q4
32 quarters
|
|
|
THS
3703
DELISTED
Treehouse Foods
THS
| $2.99M | ﹤0.01% |
85,053
-231,375
| -73% | -$8.43M |
2013 Q2
46 quarters
|
|
|
LGO
3704
Largo
LGO
$54.4M
| $2.99M | ﹤0.01% |
193,425
-6,748
| -3% | -$13.8K |
2021 Q2
14 quarters
|
|
3705
PUT
PPG Industries
PPG
$23.4B
| $2.99M | ﹤0.01% |
25,000
| – | – |
2023 Q2
6 quarters
|
|
3706
NCR Voyix
VYX
$925M
| $2.99M | ﹤0.01% |
215,753
+9,881
| +5% | +$137K |
2013 Q2
46 quarters
|
|
3707
First Trust AAA CMBS ETF
CAAA
$34.5M
| $2.98M | ﹤0.01% |
147,833
| – | – |
2024 Q1
3 quarters
|
|
3708
Kforce
KFRC
$947M
| $2.98M | ﹤0.01% |
52,511
+10,565
| +25% | +$614K |
2015 Q4
36 quarters
|
|
|
AXON
3709
CALL
Axon Enterprise
AXON
$33.6B
| $2.97M | ﹤0.01% |
5,000
-20,000
| -80% | -$10.9M |
2024 Q2
2 quarters
|
|
|
AXON
3710
PUT
Axon Enterprise
AXON
$33.6B
| $2.97M | ﹤0.01% |
+5,000
| New | +$2.72M |
2024 Q4
0 quarters
|
|
3711
Sturm, Ruger & Co
RGR
$709M
| $2.97M | ﹤0.01% |
83,940
+23,081
| +38% | +$898K |
2015 Q2
38 quarters
|
|
|
NXDR
3712
Nextdoor Holdings
NXDR
$944M
| $2.97M | ﹤0.01% |
1,252,571
+527,226
| +73% | +$1.31M |
2022 Q2
10 quarters
|
|
3713
CALL
BILL Holdings
BILL
$3.72B
| $2.96M | ﹤0.01% |
+35,000
| New | +$2.61M |
2024 Q4
0 quarters
|
|
|
3714
PUT
BILL Holdings
BILL
$3.72B
| $2.96M | ﹤0.01% |
+35,000
| New | +$2.61M |
2024 Q4
0 quarters
|
|
3715
dLocal
DLO
$4.04B
| $2.96M | ﹤0.01% |
262,951
-230,238
| -47% | -$2.32M |
2022 Q1
11 quarters
|
|
|
SRTA
3716
Strata Critical Medical Inc
SRTA
$418M
| $2.96M | ﹤0.01% |
695,536
-25,543
| -4% | -$97.2K |
2022 Q1
11 quarters
|
|
3717
EyePoint Inc
EYPT
$280M
| $2.95M | ﹤0.01% |
395,444
+23,686
| +6% | +$220K |
2019 Q2
22 quarters
|
|
|
SEMR
3718
DELISTED
Semrush
SEMR
| $2.94M | ﹤0.01% |
247,735
-139,256
| -36% | -$1.87M |
2021 Q4
12 quarters
|
|
3719
Claros Mortgage Trust
CMTG
$174M
| $2.94M | ﹤0.01% |
649,674
+170,244
| +36% | +$1.06M |
2022 Q1
11 quarters
|
|
3720
Arbutus Biopharma
ABUS
$882M
| $2.93M | ﹤0.01% |
896,258
+806,672
| +900% | +$2.97M |
2020 Q4
16 quarters
|
|
3721
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
| $2.93M | ﹤0.01% |
95,268
+12,963
| +16% | +$399K |
2017 Q1
31 quarters
|
|
3722
Weave Communications
WEAV
$593M
| $2.92M | ﹤0.01% |
183,406
+38,729
| +27% | +$545K |
2021 Q4
12 quarters
|
|
3723
Tiptree Inc
TIPT
$646M
| $2.92M | ﹤0.01% |
139,797
+60,595
| +77% | +$1.27M |
2017 Q4
28 quarters
|
|
3724
Scholar Rock
SRRK
$5.7B
| $2.91M | ﹤0.01% |
67,271
+28,545
| +74% | +$929K |
2018 Q3
25 quarters
|
|
3725
Equinor
EQNR
$101B
| $2.91M | ﹤0.01% |
122,652
+28,385
| +30% | +$682K |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.